Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Core Laboratories NV

Company price
9.04 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
446294
Market Cap
562.54M
P/E
23.58

Momentum Score

…

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.98
Low
9.24
High
52 Week Price Range
9.78
Low
20.32
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Core Laboratories NV provides technical services and products that help oil and gas companies characterize reservoirs, optimize production and enhance recovery through laboratory analyses, well diagnostics and consulting on a global basis. Long-term growth may be supported by persistent energy demand, efforts to maximize recovery from mature fields and periodic increases in upstream capital spending. The company appears positioned with specialized technical expertise, recurring testing services and a broad field footprint that could support steady cash flows.

Key risks include sensitivity to oil and gas capital spending and commodity cycles, client concentration and competition from larger service providers, and longer-term regulatory and demand shifts related to the energy transition that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
9.04
Dividend Yield
0.33%
Revenue TTM
519.18M
Revenue Per Share
11.26
Gross Profit TTM
101.32M
Debt / Equity
0.62
ROE
9.05%
Net Debt
141.32M
ROCE
11.81%
Diluted EPS TTM
0.52

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 45.90M 46.19M 41.21M 29.95M 36.11M
Minority interest -0.72M -0.75M -0.35M -0.20M -0.49M
Net income 29.67M 31.40M 36.67M 19.45M 19.73M
Selling general administrative 44.23M 38.59M 40.26M 38.12M 44.17M
Selling and marketing expenses - - 1.36M - -
Gross profit 94.28M 88.37M 94.05M 78.92M 83.84M
Reconciled depreciation 14.65M 14.95M 15.78M 17.16M 18.52M
Ebit 56.47M 58.56M 54.64M 41.52M 45.26M
Ebitda 71.12M 73.51M 70.42M 58.69M 63.78M
Depreciation and amortization 14.65M 14.95M 15.78M 17.16M 18.52M
Operating income 50.49M 58.56M 54.64M 41.52M 45.26M
Other operating expenses 476.03M 465.29M 455.15M 448.21M 430.58M
Interest expense 10.57M 12.37M 13.43M 11.57M 9.15M
Tax provision 13.37M 14.03M 4.18M 10.30M 15.89M
Interest income 10.57M 12.37M 13.43M 11.57M 9.15M
Net interest income -10.57M -12.37M -13.43M -11.57M -9.15M
Extraordinary items - - - 0.00M 0.00M
Income tax expense 15.51M 14.03M 4.18M 10.30M 15.89M
Total revenue 526.52M 523.85M 509.79M 489.74M 470.25M
Total operating expenses 43.80M 29.82M 39.41M 37.40M 44.17M
Cost of revenue 432.24M 435.48M 415.74M 410.82M 386.41M
Total other income expense net -4.59M -12.37M -13.43M -11.57M -9.15M
Net income from continuing ops 30.39M 32.15M 37.02M 19.66M 20.22M
Net income applicable to common shares 31.80M 31.40M 36.67M 19.45M 19.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 584.01M 590.41M 586.39M 578.35M 580.85M
Intangible assets 7.12M 6.40M 6.93M 7.48M 8.14M
Other current assets 16.67M 20.69M 13.25M 28.92M 29.08M
Total liab 311.80M 332.67M 356.59M 389.40M 419.85M
Total stockholder equity 265.99M 251.99M 224.81M 188.95M 161.00M
Deferred long term liab - - - 54.69M 63.44M
Other current liab 51.73M 31.06M 32.38M 39.65M 40.95M
Common stock 0.47M 0.47M 0.47M 1.19M 1.19M
Capital stock 0.47M 0.47M 0.47M 1.19M 1.19M
Retained earnings 172.66M 150.28M 120.76M 85.95M 68.35M
Other liab - - - 75.57M 91.15M
Good will 105.79M 99.44M 99.44M 99.44M 99.44M
Other assets 102.64M 224.93M 0.00M 102.32M 107.72M
Cash 22.70M 19.16M 15.12M 15.43M 17.70M
Cash and equivalents 22.85M 19.16M - 15.43M 17.70M
Total current liabilities 106.02M 97.59M 88.10M 103.14M 90.78M
Current deferred revenue 5.55M 9.33M 4.75M 5.94M 7.76M
Net debt 141.32M 160.99M 200.26M 206.96M 232.56M
Short term debt 11.46M 10.69M 10.18M 11.70M 12.34M
Short long term debt total 164.02M 180.14M 215.38M 222.39M 250.26M
Other stockholder equity 98.66M 107.01M 108.56M 105.59M 101.60M
Property plant equipment 153.79M 153.55M - 157.41M 172.34M
Total current assets 214.66M 226.61M 223.14M 211.70M 189.06M
Long term investments 4.43M 5.08M 4.84M 4.45M 4.16M
Net tangible assets - - - 115.64M -58.46M
Net receivables 120.80M 127.36M 123.07M 106.91M 96.83M
Long term debt 110.25M 126.11M 163.13M 172.39M 188.64M
Inventory 54.50M 59.40M 71.70M 60.45M 45.44M
Accounts payable 37.27M 34.55M 33.51M 45.85M 29.73M
Noncontrolling interest in consolidated entity - - - 4.70M 4.55M
Accumulated other comprehensive income -5.81M -5.77M -4.97M -3.78M -10.13M
Common stock total equity - - - 1.19M 1.19M
Retained earnings total equity - - - 85.95M 68.35M
Treasury stock - - - -1.36M -4.08M
Non currrent assets other 30.84M 29.71M 98.58M -73.02M -74.62M
Non current assets total 369.35M 363.80M 363.26M 366.65M 391.80M
Capital lease obligations 53.77M 54.03M 52.25M 50.00M 61.63M
Long term debt total 110.25M 126.11M - 172.39M 188.64M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -6.39M -6.65M -3.86M -10.22M
Change to liabilities - - - 3.64M 6.57M
Total cashflows from investing activities -2.23M -6.39M -6.65M -3.86M -10.22M
Net borrowings -15.00M -38.00M -9.00M -17.21M -71.00M
Total cash from financing activities -31.25M -45.96M -18.45M -23.38M -22.46M
Change to operating activities - - - -13.63M -11.37M
Net income 30.39M 32.15M 37.02M 19.66M 20.22M
Change in cash 3.54M 4.04M -0.31M -2.27M 3.90M
Begin period cash flow 19.16M 15.12M 15.43M 17.70M 13.81M
End period cash flow 22.70M 19.16M 15.12M 15.43M 17.70M
Total cash from operating activities 37.03M 56.39M 24.79M 24.96M 36.58M
Issuance of capital stock - - 0.00M 0.00M 60.00M
Depreciation 14.65M 14.95M 15.78M 17.16M 18.52M
Other cashflows from investing activities 13.74M 6.63M 3.93M 6.36M 2.44M
Dividends paid 1.87M 1.88M 1.87M -1.85M -1.83M
Change to inventory 2.64M 9.37M -12.98M -14.86M -4.55M
Change to account receivables -4.95M -3.61M -2.62M -10.08M -13.52M
Sale purchase of stock -12.43M -5.31M -2.20M -3.90M -8.26M
Other cashflows from financing activities -1.96M -0.78M -5.38M 113.38M 153.63M
Change to netincome - - - 12.71M 9.84M
Capital expenditures 14.74M 13.03M 10.58M 10.22M 13.54M
Change receivables - - - -10.08M -13.52M
Cash flows other operating - - - -3.27M -0.32M
Cash and cash equivalents changes - - - -2.27M 3.90M
Change in working capital -14.53M 7.88M -28.77M -9.56M -11.50M
Stock based compensation 7.14M 3.75M 13.97M 7.76M 19.09M
Other non cash items -2.04M -3.03M -2.41M -10.49M -15.76M
Free cash flow 22.29M 43.36M 14.21M 14.74M 23.04M

Peer Comparison*

Sector: Energy Industry: Oil & Gas Equipment & Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CLB
Core Laboratories NV
-
-%
9.04 23.58 19.76 1.08 2.06 1.35 11.22
SLB
SLB N.V.
1.06
2.12%
50.96 26.44 16.31 2.21 3.04 2.42 13.18
BKR
Baker Hughes Co
1.64
3.43%
49.41 18.24 17.57 2.03 2.83 2.05 11.20
HAL
Halliburton Company
-
-%
32.93 18.29 12.12 1.33 2.65 1.58 9.83
FTI
TechnipFMC PLC
0.84
1.30%
65.39 25.50 21.74 2.82 8.73 2.77 14.51

Profile*

Core Laboratories NV

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

6316 Windfern Road, Houston, TX, United States, 77040

713 328 2673

3300

Name Title Year Born
Mr. Lawrence V. Bruno Chairman, CEO, Pres & COO 1960
Mr. Christopher Scott Hill Sr. VP & CFO 1970
Ms. Gwendolyn Y. Gresham M.B.A. Sr. VP of Corp. Devel. & Investor Relations 1968
Mr. Mark Damian Tattoli Sr. VP, Sec. & Gen. Counsel 1972
Mr. Kevin G. Daniels Chief Accounting Officer, Treasurer & VP 1964
Mr. Jacobus Schouten Managing Director 1955
J. Donald Dumas Jr. Sr. VP of Production Enhancement & Bus. Devel. NA
Mr. Lawrence V. Bruno Chairman of the Board, CEO, President & COO 1959
Mr. Christopher Scott Hill Senior VP & CFO 1970
Ms. Gwendolyn Y. Gresham M.B.A. Senior Vice President of Corporate Development & Investor Relations 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…